CHASE WILLIAM J
SEC CIK 1563572 · EDGAR
BoughtSold
Most active insiders at GRAL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ILLUMINA, INC. | 10% | — | $79.85M |
| 2 | Ofman Joshua J. | Pres, Dir | — | $18.72M |
| 3 | RAGUSA ROBERT P | CEO, Dir | — | $12.76M |
| 4 | Freidin Aaron | CFO | — | $6.59M |
| 5 | Partridge Andrew John | Chief Growth Off | — | $91.1K |
| 6 | Krevans Sarah | Dir | — | — |
| 7 | CHASE WILLIAM J | Dir | — | — |
| 8 | MIZELL STEVEN | Dir | — | — |
| 9 | SUMME GREGORY L | Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-16 16:43 | 2026-07-15 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $74.36 | +276 | 43.0K | +0.6% | +$20.5K | |
| 2026-06-22 17:30 | 2026-06-18 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $63.74 | +5,491 | 42.7K | +15% | +$350.0K | |
| D | 2026-06-10 19:00 | 2026-06-09 | NTLA | Intellia Therapeutics, Inc. | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +9,200 | 143.9K | +7% | $0 |
| 2026-04-17 16:07 | 2026-04-15 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $49.79 | +408 | 37.2K | +1% | +$20.3K | |
| 2026-01-16 | 2026-01-15 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $97.44 | +213 | 36.8K | +0.6% | +$20.8K | |
| 2025-10-16 | 2025-10-15 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $75.52 | +275 | 36.6K | +0.8% | +$20.8K | |
| 2025-08-22 | 2025-08-20 | NTLA | Intellia Therapeutics, Inc. | CHASE WILLIAM J | Dir | P - Purchase | $10.03 | +100.0K | 134.7K | +288% | +$1.00M | |
| 2025-07-17 | 2025-07-15 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $38.53 | +533 | 36.3K | +1% | +$20.5K | |
| D | 2025-06-13 | 2025-06-11 | NTLA | Intellia Therapeutics, Inc. | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +8,000 | 34.7K | +30% | $0 |
| 2025-05-30 | 2025-05-29 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $41.10 | +6,082 | 35.8K | +20% | +$250.0K | |
| 2025-04-16 | 2025-04-15 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $25.94 | +784 | 29.7K | +3% | +$20.3K | |
| 2025-01-16 | 2025-01-15 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $17.58 | +1,182 | 28.9K | +4% | +$20.8K | |
| 2024-11-01 | 2024-10-30 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $13.62 | +210 | 27.7K | +0.8% | +$2,860 | |
| 2024-10-17 | 2024-10-15 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $14.01 | +1,054 | 27.5K | +4% | +$14.8K | |
| 2024-06-27 | 2024-06-25 | GRAL | GRAIL, Inc. | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +26.5K | 26.5K | New | $0 | |
| D | 2024-06-14 | 2024-06-12 | NTLA | Intellia Therapeutics, Inc. | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +7,737 | 26.7K | +41% | $0 |
| D | 2023-06-16 | 2023-06-14 | NTLA | Intellia Therapeutics, Inc. | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +1,673 | 19.0K | +10% | $0 |
| D | 2023-04-18 | 2023-04-14 | NTLA | Intellia Therapeutics, Inc. | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +10.5K | 17.3K | +154% | $0 |
Purchase Sale Sale after option exercise All abbreviations